Thus, we hypothesized that dual ROCK/MYLK4 blockade with ITRI-ES would provide superior neuroprotection in NMOSD-related optic neuritis by simultaneously suppressing converging mechanisms of barrier breakdown and immune activation, beyond what single-pathway inhibition could achieve. Here, MYLK4 is linked to optic neuritis.